# Asepha

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/asepha

- Industry: Software
- Headquarters: Toronto, Canada
- Website: www.asepha.ai
- Total disclosed funding: $4M
- Latest round: Seed (Jul 9, 2025)
- Investors on record: 7

## About

Asepha, based in Canada, specializes in AI-driven workflow automation solutions tailored for the pharmacy sector, enhancing operational efficiency and streamlining processes through advanced technologies.Founded in 2025, Asepha is focused on providing innovative automation solutions for pharmacies. The company is headquartered in Toronto, Canada. Recently, on July 9, 2025, Asepha raised USD 4.00 mn in a Seed funding round, co-led by Glasswing Ventures and Core Innovation Capital, with contributions from other investors including Panache Ventures, RedBud VC, MGV Capital Group, Ripple Ventures, and Front Row Ventures. This investment supports Asepha's growth strategy as it continues to develop its offerings.Asepha specializes in AI-powered workflow automation solutions designed specifically for the pharmacy sector. Its core product offerings include automatic prescription filtering and data entry into Pharmacy Management Systems (PMS) and Electronic Health Records (EHR), which streamline manual tasks to enhance operational efficiency. Asepha's technology captures critical data to assess patient eligibility for medications, thereby reducing delays in therapy initiation. The company also provides a Call & SMS Assistant to alleviate the workload on pharmacy staff by addressing common inquiries and offering updates on prescription statuses. Furthermore, Asepha's medication reconciliation tools identify discrepancies in medication lists, and its medication review function highlights potential drug therapy problems for pharmacist review. The solutions are trusted by pharmacists across markets in the United States, Canada, Australia, and New Zealand, serving a diverse client base that includes retail and hospital pharmacies.Asepha generates revenue primarily through subscriptions to its suite of AI-driven pharmacy automation tools. Clients, including retail and institutional pharmacies, engage with Asepha’s platforms on a subscription basis, which may include tiered pricing models based on the number of users or the scale of operations. As part of their offerings, Asepha’s flagship products facilitate efficient workflows, leading to increased productivity and revenue growth for their pharmacy clients. The transaction structure typically involves direct business-to-business interactions, where pharmacies pay for access to specific services such as instant prior authorization and medication reconciliation. By optimizing pharmacy operations, Asepha enables its clients to capture new revenue streams without necessitating an increase in staff headcount.In July 2025, Asepha raised USD 4.00 mn in Seed funding, which will be utilized to accelerate its market presence and engineering team in the United States. The company is planning to introduce new products designed to further enhance pharmacy automation capabilities and is targeting expansion into additional markets within North America and potentially into Europe by the end of 2026.

## Funding rounds

- Seed, Jul 9, 2025, $4M — Core Innovation Capital, Glasswing Ventures, Ripple Ventures, Panache Ventures, Front Row Ventures, MGV Capital Group, Redbud VC

## Investors

- Core Innovation Capital (https://capitalatlas.ai/funds/core-innovation-capital) — Seed
- Glasswing Ventures (https://capitalatlas.ai/funds/glasswing-ventures) — Seed
- Ripple Ventures (https://capitalatlas.ai/funds/ripple-ventures) — Seed
- Panache Ventures (https://capitalatlas.ai/funds/panache-ventures) — Seed
- Front Row Ventures (https://capitalatlas.ai/funds/front-row-ventures) — Seed
- MGV Capital Group (https://capitalatlas.ai/funds/mgv-capital-group) — Seed
- Redbud VC (https://capitalatlas.ai/funds/redbud-vc) — Seed